In conclusion, we have identified a mutation in KCNK16 that causes a gain of function in TALK-1 and reduces glucose-stimulated Ca2+ influx, Ca2+ER storage, and GSIS, resulting in MODY. The gene discussed is KCNK16; the disease is MODY.